US Stock MarketDetailed Quotes

ASND Ascendis Pharma A/S

Watchlist
  • 144.080
  • +1.590+1.12%
Close Feb 14 16:00 ET
8.62BMarket Cap-21.05P/E (TTM)

Ascendis Pharma A/S Key Stats

Ascendis Pharma A/S Q4 2024 Earnings Date

Currency:USDFeb 12, 2025

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
Revenue
124.45M
180.98M
+56.53M
Beat Est.
-18.12%
+19.07%
+45.42%
EPS
-1.22
-0.67
+0.55
Beat Est.
+28.30%
+60.82%
+45.35%
Strong Buy

Feb 15, 2025

Ascendis Pharma A/S Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 9 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: EUR

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 124.625M--
--2025/Q1-- / 93.305M--
Feb 12, 20252024/Q4173.916M / 119.596M--
Nov 14, 20242024/Q357.833M / 70.312M--
Sep 3, 20242024/Q235.998M / 84.468M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 124.625M--
--2025/Q1-- / 93.305M--
Feb 12, 20252024/Q4173.916M / 119.596M--
Nov 14, 20242024/Q357.833M / 70.312M--
Sep 3, 20242024/Q235.998M / 84.468M--

Unlock Free Earnings Estimates

Ascendis Pharma A/S Earnings Reports

Read more

Trending Stocks

Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
Discussing
FOMC leaves rates unchanged, how will you adjust your portfolio?
FOMC left the target Federal Funds rate unchanged at at target of 4.25%-4.5%, how will you adjust your portfolio? Show More